 |
Top 239 Cancer treatment startups
Nov 26, 2024 | By Jason Kwon | 29 |
Oncology startups develop new cancer treatments and diagnostics technologies, like genome analysis, patient big data analyses, AI, immunotherapy, antibody therapy, gene therapy, stem cells, nanoparticles for drug-delivery...
1
Country: Switzerland | Funding: $101.8M
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
2
Country: Denmark | Funding: $249.6M
ADCendo is dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression.
ADCendo is dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression.
3
Country: USA | Funding: $207.5M
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides with applications in Rb-dysregulated cancers and cyclin-E-dependent malignancies
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides with applications in Rb-dysregulated cancers and cyclin-E-dependent malignancies
4
Country: USA | Funding: $119M
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
5
Country: USA | Funding: $54.5M
Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.
Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.
6
Country: Ireland | Funding: $20.1M
Luminate develops world's first portable, comfortable, and effective treatment for chemotherapy induced hair loss.
Luminate develops world's first portable, comfortable, and effective treatment for chemotherapy induced hair loss.
7
Country: USA | Funding: $1.8M
Veris Health is a digital health company that provides cancer care platform.
Veris Health is a digital health company that provides cancer care platform.
8
Country: USA | Funding: $259M
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
9
Country: USA | Funding: $226.6M
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
10
Country: USA | Funding: $177M
Thyme Care is a provider of oncology care management solutions.
Thyme Care is a provider of oncology care management solutions.
11
Country: USA | Funding: $3.9B
At Moderna, we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells.
At Moderna, we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells.
12
Country: UK | Funding: $1.1B
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
13
Country: India | Funding: $16M
OneCell Diagnostics is a precision oncology liquid biopsy diagnostics company.
OneCell Diagnostics is a precision oncology liquid biopsy diagnostics company.
14
Country: USA | Funding: $178.2M
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
15
Country: USA | Funding: $87.6M
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
16
Country: USA | Funding: $630.8M
ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop in immune cell therapies.
ArsenalBio is focused on integrating technologies such as CRISPR-based genome engineering, scaled and high throughput target identification, synthetic biology, and machine learning to advance a new paradigm to discover and develop in immune cell therapies.
17
Country: USA | Funding: $535.8M
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
18
Country: UK | Funding: $64.3M
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population.
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population.
19
Country: UK | Funding: $188M
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
20
Country: Germany | Funding: $2.1B
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
